Align Technology, Inc. (NASDAQ:ALGN) Shares Acquired by Swedbank AB

Swedbank AB grew its stake in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 25.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 486,267 shares of the medical equipment provider's stock after acquiring an additional 97,152 shares during the quarter. Swedbank AB owned about 0.65% of Align Technology worth $101,392,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Quarry LP boosted its position in shares of Align Technology by 53.0% in the 2nd quarter. Quarry LP now owns 127 shares of the medical equipment provider's stock worth $31,000 after purchasing an additional 44 shares in the last quarter. Empirical Finance LLC boosted its holdings in Align Technology by 2.1% in the third quarter. Empirical Finance LLC now owns 2,486 shares of the medical equipment provider's stock worth $632,000 after acquiring an additional 50 shares in the last quarter. Lake Street Advisors Group LLC grew its holdings in shares of Align Technology by 5.6% during the third quarter. Lake Street Advisors Group LLC now owns 1,042 shares of the medical equipment provider's stock valued at $265,000 after buying an additional 55 shares during the last quarter. Crestwood Advisors Group LLC increased its position in shares of Align Technology by 6.6% in the 3rd quarter. Crestwood Advisors Group LLC now owns 1,000 shares of the medical equipment provider's stock valued at $254,000 after acquiring an additional 62 shares during the period. Finally, Mather Group LLC. raised its stake in Align Technology by 51.6% in the 3rd quarter. Mather Group LLC. now owns 185 shares of the medical equipment provider's stock worth $47,000 after acquiring an additional 63 shares during the last quarter. 88.43% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently commented on ALGN. Piper Sandler dropped their price objective on shares of Align Technology from $285.00 to $275.00 and set an "overweight" rating on the stock in a research note on Thursday, October 24th. Bank of America raised their target price on Align Technology from $200.00 to $206.00 and gave the company an "underperform" rating in a research report on Friday, December 13th. Robert W. Baird reduced their price target on Align Technology from $325.00 to $276.00 and set an "outperform" rating for the company in a report on Thursday, October 24th. Stifel Nicolaus cut their target price on shares of Align Technology from $285.00 to $275.00 and set a "buy" rating for the company in a research note on Thursday, October 24th. Finally, Leerink Partners upgraded Align Technology from a "market perform" rating to an "outperform" rating and lifted their price objective for the stock from $235.00 to $280.00 in a report on Monday, January 6th. Two research analysts have rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Align Technology has an average rating of "Moderate Buy" and a consensus target price of $267.45.

Align Technology Trading Up 1.4 %

NASDAQ:ALGN traded up $3.21 during trading hours on Thursday, hitting $227.66. The company had a trading volume of 219,087 shares, compared to its average volume of 570,303. Align Technology, Inc. has a 1 year low of $196.09 and a 1 year high of $335.40. The company has a market cap of $16.99 billion, a P/E ratio of 38.84, a P/E/G ratio of 5.14 and a beta of 1.67. The company has a 50-day moving average of $223.14 and a 200 day moving average of $227.20.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.